Related references
Note: Only part of the references are listed.Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment
Aika Miya et al.
JOURNAL OF DIABETES INVESTIGATION (2021)
Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes
M. B. Christensen et al.
DIABETES & METABOLISM (2020)
Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution
David Rodbard
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes
Fraser W. Gibb et al.
DIABETOLOGIA (2020)
Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
Monica Andrade Lima Gabbay et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Japanese Clinical Practice Guideline for Diabetes 2019
Eiichi Araki et al.
DIABETOLOGY INTERNATIONAL (2020)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes
Makoto Ohara et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
GlyCulator2: an update on a web application for calculation of glycemic variability indices
Konrad Pagacz et al.
ACTA DIABETOLOGICA (2018)
Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naive Japanese patients with type 2 diabetes mellitus
Ryo Suzuki et al.
DIABETES OBESITY & METABOLISM (2018)
Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
Jingyi Lu et al.
DIABETES CARE (2018)
Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study)
Harpreet S. Bajaj et al.
DIABETES CARE (2017)
Metrics for glycaemic control - from HbA1c to continuous glucose monitoring
Boris P. Kovatchev
NATURE REVIEWS ENDOCRINOLOGY (2017)
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne et al.
DIABETES CARE (2017)
Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c
Xixiang Tang et al.
CLINICA CHIMICA ACTA (2016)
The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
Ji Eun Jun et al.
CARDIOVASCULAR DIABETOLOGY (2015)
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Timothy Bailey et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2015)
Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome
Masaomi Gohbara et al.
CIRCULATION JOURNAL (2015)
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
John M. Lachin et al.
DIABETES (2014)
Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: An analysis of 480 subjects
Sang-Man Jin et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Hypo- and Hyperglycemia in Relation to the Mean, Standard Deviation, Coefficient of Variation, and Nature of the Glucose Distribution
David Rodbard
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
Shogo Funakoshi et al.
JOURNAL OF DIABETES INVESTIGATION (2011)
Glycemic Variability Correlates Strongly With Postprandial β-Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents
Klaus-Dieter Kohnert et al.
DIABETES CARE (2009)
Share Paper
